Salesforce advocates for environmental regulation of AI, pushing for standardized disclosure of energy usage and emissions. They also ended acquisition talks with Informatica. CRM stock gained 41% in past year.
Salesforce Inc (NYSE: CRM) discontinues negotiations to acquire Informatica Inc (NYSE: INFA) due to disagreements on the acquisition terms. Talks were close to making it one of Salesforce's most significant purchases, as per sources familiar with Reuters.
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Salesforce is reportedly in advanced negotiations to acquire Informatica, according to a Wall Street Journal report from Friday. Reportedly, the discussed acquisition amount is lower than Informatica's recent closing stock price which may be complicating the matter.